Search
Now showing items 1-2 of 2
Comparison of Pathways and Detection Strategies for Pancreatic Ductal Adenocarcinoma (PDAC) Using Genetically Engineered Mouse Model (GEMM)
(2022-04)
Pancreatic ductal adenocarcinoma (PDAC) is a deadly, invasive pancreatic cancer with 5-year survival for patients close to 7.1%. The difficulty of researching PDAC comes from a variety of factors that lead to its development, ...
A Deep Learning Model for Pancreatic Ductal Adenocarcinoma Chemotherapy Outcome Prediction
(2022-04)
Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive abdominal malignancy, with an overall 8.5% 5-year survival rate. PDAC is often detected too late for surgical resection and associated with resistance to chemotherapy ...